擔任BioMedicine （Q1, IF 2.5）這個期刊的客座主編

最近我被邀請擔任BioMedicine （Q1, IF 2.5）這個期刊的客座主編，負責Special Issue on Autoimmune Diseases。

歡迎各位有自體免疫或風濕病相關的基礎或臨床研究文章投稿。

這個雜誌是免費全文開放存取，而且免文章處理費。超佛心的！😁

#歡迎投稿

Dear Colleague,

We are thrilled to announce that BioMedicine has received its inaugural Impact Factor of 2.5 in 2025! As one of the few open-access journals without Article Processing Charges (APCs), BioMedicine publishes high-quality research across clinical, laboratory, and population health sciences.

We are now launching a Special Issue on Autoimmune Diseases, to be published in December 2026, aiming to showcase innovative research on mechanisms, diagnostics, prevention, and therapies for autoimmune conditions. 

Topics include, but are not limited to:

Immune checkpoint dysregulation and autoimmunity

Microbiome alterations and autoimmune disease

Genetic, epigenetic, and proteomic biomarkers

Autoantibodies and pathogenic mechanisms

Novel therapeutics: biologics, small molecules, tolerogenic therapies

Neuroautoimmunity, pediatric autoimmunity, and post-infectious autoimmunity

Systems biology, multi-omics, and computational modeling

Translational, clinical, and population-based studies

Key Dates & Submission:

Deadline: September 15, 2026

Submission: Via our online submission system

Formatting: Follow the Author Guidelines on our website

We warmly invite researchers, clinicians, and scientists to contribute high-quality articles to this special issue.

Sincerely, 

Professor James Cheng-Chung Wei

Guest Editor for Special Issue, BioMedicine

Institute of Medicine, Chung Shan Medical University

Department of Allergy, Immunology, and Rheumatology

Chung Shan Medical University Hospital, Taichung, Taiwan